Moderna – 2024 Shareholder Letter from CEO Stéphane Bancel

Moderna has added its 2024 Shareholder Letter from CEO Stéphane Bancel to its website.

As we reflect on 2024, it is clear that the past year brought formidable challenges for Moderna along with significant advances, particularly for our development pipeline. With a continuous learning mindset, we analyzed these outcomes and adapted our business strategy based on our successes and challenges. We are confident that with our industry-leading mRNA platform, technology, resources and team, we are well-positioned to execute this strategy and continue building a future where Moderna leads in healthcare innovation, delivering on our Mission for patients in 2025 and beyond.

Click here to read the full 2024 shareholder letter from Moderna CEO Stéphane Bancel